Τόμος 24 (2010) – Τεύχος 2 – Άρθρο 70 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 24 (2010) – Issue 2 – Article 70 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Association study of the single nucleotide polymorphism (SNP), rs6983267, at region 3 of chromosome 8q24, with prostate cancer in the Greek population
Authors Amalia Papanikolopoulou1, Olfert Landt2, Martin Reczko3 and Nikolaos Drakoulis1

1. Dept of Pharmaceutical Technology, School of Pharmacy, University of Athens, Greece

2. TIB MOLBIOL, Berlin, Germany

3. Biomedical Sciences Research Center, Alexander Fleming, Vari, Greece

Citation Papanikolopoulou, A., Landt, O., Reczko, M., Drakoulis, N.: Association study of the single nucleotide polymorphism (SNP), rs6983267, at region 3 of chromosome 8q24, with prostate cancer in the Greek population, Epitheorese Klin. Farmakol. Farmakokinet. 24(2): 187-189 (2010)
Publication Date 2010
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Genetic variants, prostate cancer, chr8q24 and SNPs, prevalence of rs6983267.
Other Terms Review article
Summary Recently, common variants on human chromosome 8q24 were found to be associated with prostate cancer risk. While conducting an association study at the Greek population to investigate the frequency and the susceptibility of one SNP, rs6983267, located at the region 3 of chromosome 8q24, to the prostate cancer, we found highly significant correlation (Odds ratio=2.83 and p-value=0.002). Comparing the findings to other studies, conducted in northern Europeans, the population attributable risk (PAR%) and the frequency of the at risk allele (G vs T) were higher at the Greek population with an independent risk for the carriers to develop the disease.
References 1. Fitzpatrick J.M.: Optimizing the management of prostate diseases: prostate cancer. BJU International 101(sup2): 1 (2008)

2. Crawford, E.D. Epidemiology of prostate cancer. Urology 62: 3-12 (2003)

3. NCΙ SEER Program, Ries LAG et al editors: Cancer of the Prostate (Invasive) SEER Incidence and U.S. Death Rates, Age-Adjusted and Age-Specific Rates, by Race 2002-2006 Annual SEER Cancer Statistics Review (CSR), 1975-2006

4. Xu J., Dimitrov L., Chang B.-L., Adams T.S., Turner A.R., Meyers D.A., et al.: A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am. J. Hum. Genet. 77: 219-229 (2005)

5. Amundadottir L.T., Sulem P., Gudmundsson J., et al.: A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38: 652-658 (2006)

6. Yeager M., Orr N., Hayes R.B., et al.: Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39: 645-649 (2007)

7. Haiman C.A., Patterson N., Freedman M.L., et al.: Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet. 39: 638-644 (2007)

8. Zheng S.L., Sun J., Cheng Y., et al.: Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J. Natl. Cancer Inst. 99: 1525-1533 (2007)

9. Robbins C., Torres J.B., Hooker S. et al.: Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res. 17: 1717-1722 (2007)

10. Al Olama A.A., Kote-Jarai Z., Giles G.G., et al.: Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat. Genet. 41:1058-1060 (2009)

11. Zheng S.L., Sun J., Wiklund Fr., et al.: Cumulative association of five genetic variants with prostate cancer. N. Engl. J. Med. 358: 910-919 (2008)

12. Gudmundsson J., Sulem P., Steinthorsdottir V., et al.: Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet. 39: 977-983 (2007)

13. FitzGerald L.M., Patterson B., Thomson R., Polanowski A., Quinn S., Brohede J., Thornton T., Challis D., Mackey D.A., Dwyer T., Foote S., Hannan G.N., Stankovich J., McKay J.D., Dickinson J.L.: Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease. Eur. J. Hum. Genet. 7: 368-377 (2009)

14. Cohen J.: Statistical Power Analysis for the Behavioural Sciences. 2nd ed., Hillsdale, NJ: Lawrence Erlbaum, 1988

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2010 – ANNUAL SUBSCRIPTION 2010
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

Bookmark the permalink.

Comments are closed.